Abstract
Ulcerative colitis and Crohn’s disease are inflammatory diseases of unknown etiology. Not only are the etiologies unknown, but the soluble mediators that amplify and modulate the inflammatory response have not been fully explored. Our studies have focused on delineating the soluble mediators of inflammation in IBD with emphasis on the role played by arachidonic acid metabolites, particularly the lipoxygenase product, leukotriene B4 (LTB4), in inflammatory bowel disease (IBD).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Donowitz M: Arachidonic acid metabolites and their role in inflammatory bowel disease. An update requiring addition of a pathway. Gastroenterology 88: 580–587, 1985.
Rampton DS, Hawkey CJ: Prostaglandins and ulcerative colitis. Gut 25: 1399–1413, 1984.
Sharon P, Ligumsky M, Rachmilewitz, D and Zor U: Role of prostaglandins in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine. Gastroenterology 75: 638–640, 1978.
Gould SR, Brash AR, Connolly ME and Lennard-Jones JE: Studies of prostaglandins and sulphasalazine in ulcerative colitis. Prostaglandins and Medicine 6: 165–182, 1981.
Ford-Hutchinson AW, Bray MA, Doig MV, Shipley ME and Smith JF: Leukotriene B, a potent chemotactic and aggregating substance released from polymorphonuclear leukocytes. Nature (1984) 266: 264–265.
Musch MW, Kachur JF, Miller RJ and Field M: Bradykinin stimulated electrolyte secretion in rabbit and guinea pig intestine: involvement of arachidonic acid metabolites. J. Clin Invest. 71: 1073–83, 1983.
Sharon P, Stenson WF: Enhanced synthesis of leukotriene B4 by colonic mucosa in inflammatory bowel disease. Gastroenterology 86: 453–460, 1984.
Broughton-Smith NK, Hawkey CJ and Whittle BJR: Biosynthesis of lipoxygenase and cyclooxygenase products from 14C-arachidonic acid by human colonic mucosa. Gut 24: 1176–1182, 1983.
Peskar BM, Dreyling KW, May B, Thieves M, Morgenroth K, Goebell H and Peskar BA: Increased formation of leukotriene B4 and sulphidopeptide–leukotrienes by rectal mucosa of patients with Crohn’s disease and ulcerative colitis (Abstract). Gut 26: A542–A543, 1985.
Lauritsen K, Laursen LS, Bukhave K, Rask-Madsen J: Effects of systemic prednisolone on arachidonic acid metabolites determined by equilibrium in vivo dialysis of rectum in severe relapsing ulcerative colitis. (Abstract) Gastroenterology 88: 1466, 1985.
Sharon P and Stenson WF: Metabolism or arachidonic acid in acetic acid colitis in rats: Similarity to human inflammatory bowel disease. Gastroenterology, 88: 55–63, 1985.
Clark, JG and Kuhn C: Bleomycin-induced pulmonary fibrosis in hamsters: Effect of neutrophil depletion on lung collagen synthesis. Am Rev Respir Dis. 126: 737–739, 1982.
Gallin JI, Clark RA and Kaplan AP: Granulocyte chemotaxis, an improved in vitro assay employing Cr-labeled granulocytes. J. Immunol. 110: 233–240, 1973.
Das KM and Dubin R: Clinical pharmacokinetics of sulfasalazine. Clin Pharmacokinetics 1: 406–425, 1976.
Stenson WF and Lobos E: Sulfasalazine inhibits the synthesis of chemotactic lipids by neutrophils. J. Clin. Invest 69: 494–497, 1982.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Martinus Nijhoff Publishers
About this chapter
Cite this chapter
Stenson, W.F. (1986). Role of Lipoxygenase Products as Mediators of Inflammation in IBDa . In: Rachmilewitz, D. (eds) Inflammatory Bowel Diseases 1986. Developments in Gastroenterology, vol 8. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-4269-1_9
Download citation
DOI: https://doi.org/10.1007/978-94-009-4269-1_9
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-8396-6
Online ISBN: 978-94-009-4269-1
eBook Packages: Springer Book Archive